EUVIMEDEUVIMED entdecken
Crossref

Advances in the Use of CMR in Subclinical Diabetic Cardiomyopathy

Guorong LI, Yang SUN, Tingting ZHANG

CT Lilun yu yingyong yanjiu · 2023-11 · 32 (6) · 836-842

DOI: 10.15953/j.ctta.2022.255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CT Lilun yu yingyong yanjiu, 2023-11. Verfasst von Guorong LI und 2 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DCM) presents as myocardial fibrosis, left ventricular hypertrophy, and myocardial diastolic abnormalities. Cardiac magnetic resonance (CMR) technology can quickly and accurately determine the myocardial structure and cardiac function of diabetic patients and plays a crucial role in the diagnostic and prognostic evaluation of subclinical DCM. Evaluation of subclinical DCM using CMR technology primarily involves cardiac magnetic resonance-feature tracking (CMR-FT), magnetic resonance spectroscopy (MRS), T1 mapping technology, and magnetic resonance myocardial perfusion imaging. This paper reviews the research progress of CMR technology in the diagnosis of subclinical diabetic cardiomyopathy.

Schlagwörter

cmrdiabetesdiabetic cardiomyopathymyocardial fibrosis

Zitieren

APA

LI, G., SUN, Y., & ZHANG, T. (2023). Advances in the Use of CMR in Subclinical Diabetic Cardiomyopathy. CT Lilun yu yingyong yanjiu, 32(6), 836-842. https://doi.org/10.15953/j.ctta.2022.255

Vancouver

LI G, SUN Y, ZHANG T. Advances in the Use of CMR in Subclinical Diabetic Cardiomyopathy. CT Lilun yu yingyong yanjiu. 2023;32(6):836-842. doi:10.15953/j.ctta.2022.255

BibTeX
@article{LI2023,
  author = {LI, Guorong and SUN, Yang and ZHANG, Tingting},
  title = {Advances in the Use of CMR in Subclinical Diabetic Cardiomyopathy},
  journal = {CT Lilun yu yingyong yanjiu},
  year = {2023},
  volume = {32},
  number = {6},
  pages = {836--842},
  doi = {10.15953/j.ctta.2022.255}
}
Kostenlos starten →